October 1, 2020 – New Canaan Funding Mezzanine VII SBIC, LP (“NCF VII SBIC”) provided financing to support the recapitalization of RN Enterprises (“Red Nucleus” or the “Company”) by The Riverside Company (“Riverside”). NCF provided debt financing as part of this acquisition.

Red Nucleus, headquartered in Yardley, Pennsylvania, is the premier digital learning and compliance solutions provider for the global life sciences industry. Through its Learning and Compliance services, the Company provides learning, training, and compliance services to the biopharma industry across all phases of the drug lifecycle.

New Canaan Funding (“NCF”), with offices in Naples, Florida, New Canaan, Connecticut and Wheaton, Illinois, is a mezzanine firm focused on the middle market private sponsor community. Since its beginnings in 1995, NCF has targeted acquisitions, recapitalizations and growth financings in conjunction with its private equity clients. NCF is currently investing out of its seventh fund. The investment in Red Nucleus represents NCF VII SBIC’s first investment in the fund. This financing represents the sixteenth investment with Riverside, including fifteen investments made in the prior NCF investment vehicles.

The Riverside Company fosters long-term growth through fundamental operating improvements and add-on acquisitions, preferring to partner with sellers seeking to remain involved in the company and working together to drive growth. Through more than 600 investments, Riverside has honed its approach to sourcing ‘little leading’ companies with teams of financial and operational experts delivering a fair, fast process that aims to provide successful outcomes.

Contact and additional information for The Riverside Company can be found at https://www.riversidecompany.com.

Contact at New Canaan Funding:

Mark Thies

mthies@newcanaanfunding.com 203-966-1071